Investigating kidney outcomes in patients with Tuberous Sclerosis Complex
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
This study looks at how different factors affect kidney health in people with Tuberous Sclerosis Complex and related kidney tumors to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 8 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Brest and 1 other locations) |
| Trial ID | NCT02887781 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on understanding the clinical, care-related, and genetic factors that influence renal outcomes in patients diagnosed with Tuberous Sclerosis Complex (TSC) and/or renal angiomyolipoma. By collecting data from patients in the Great West Region of France, the study aims to identify patterns and correlations that could inform better management of these conditions. Participants will include those with isolated angiomyolipoma, TSC with angiomyolipoma, or TSC alone, provided they consent to the study.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with Tuberous Sclerosis Complex or renal angiomyolipoma who are willing to participate.
Not a fit: Patients who object to participating in the study will not benefit from its findings.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and outcomes for patients with Tuberous Sclerosis Complex and related kidney issues.
How similar studies have performed: While this study is focused on a specific population, similar observational studies have shown success in identifying factors affecting outcomes in related conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria of study participants * Patient presenting with an isolated angiomyolipoma or * Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or * Patient presenting with tuberous sclerosis complex * Patient not objecting to the study Exclusion criteria of study participants ■Patient objecting to the study
Where this trial is running
Brest and 1 other locations
- CHU Brest — Brest, France (Recruiting)
- CHU Rennes — Rennes, France (Recruiting)
Study contacts
- Study coordinator: Yannick LE MEUR, MD PhD
- Email: yannick.lemeur@chu-brest.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.